Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...

GLP-1 patches, topical adhesive patches worn on your arm or abdomen that claim to deliver natural weight-loss revving ...

In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released new guidance today recommending the use of popular weight-loss ...

Of the four major GLP-1 drugs on the market, only Zepbound and Mounjaro (known generically as tirzepatide) are FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher.

As she awaited a heart ablation to treat her AFib, Dolores Catania turned to food for comfort. After her procedure, she returned to using a GLP-1.